Back to search results

Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Philadelphia Chromosome-Positive · Acute Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Montefiore Einstein Comprehensive Cancer Center, The Bronx, New York, United States

    Contact: Study coordinator (Marina Konopleva, MD) · Marina.Konopleva@einsteinmed.edu · 718-920-4826
    Contact: Principal Investigator (Marina Konopleva, MD)

  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Nicholas Short, MD) · nshort@mdanderson.org · 713-563-4485
    Contact: Principal Investigator (Nicholas Short, MD)
Study leads

  • Nicholas Short, MD

    Principal Investigator

    M.D. Anderson Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)